Vietnam MOH registration 230000152/PCBB-BYT

Lithium Quantitative Testing Drug

VN: Thuốc thử xét nghiệm định lượng lithium
Vietnam flagVietnam·Risk Class TTBYT Loại B·Atellica CH Lith_2·Siemens Healthcare Diagnostics Inc.·Registered Feb 23, 2023
Registration details
Analysis ID
230000152/PCBB-BYT
Submission ID
000.00.04.G18-230223-0004
Product Type
Atellica CH Lith_2
Product Code
11532401
Company information
Manufacturer Country
USA
Technical details
Intended Use
The Atellica CH Lithium_2 (LITH_2) test is used for in vitro diagnosis in the quantification of lithium in human serum and plasma (natri heparin, kali EDTA) using the Atellica CH Analyzer. This test is used to support the monitoring of lithium therapy.
Dates and status
Registration Date
Feb 23, 2023
Companies making similar products

Companies providing products similar to "Lithium Quantitative Testing Drug"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Lithium Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230000152/PCBB-BYT and manufactured by Siemens Healthcare Diagnostics Inc..

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Siemens Healthcare Diagnostics Inc., and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI300,000+ Devices1 Competitors1 Recent Registrations